Australia's CSL to start work on immunoglobulin product to treat COVID-19
May 05, 2020 at 20:11 PM EDT
Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.